Evidence map›Paper›PMID 41750869›Full record

ArticleFoods (Basel, Switzerland)2026

Isolation, Identification, and Validation of Strains from Commercial Probiotics: Do We Get What We Expect?

Isabella Somera de Oliveira E Silva, Emília Maria França Lima, Katia Leani, Svetoslav Dimitrov Todorov

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Antioxidant properties of bioactive metabolites produced by lactic acid bacteria isolated from tropical fruits.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Isabella Somera de Oliveira E SilvaProBacLab, Laboratório de Microbiologia de Alimentos, Departamento de Alimentos e Nutrição Experimental, Food Research Center, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, SP 05508-000, Brazil.
Emília Maria França LimaProBacLab, Laboratório de Microbiologia de Alimentos, Departamento de Alimentos e Nutrição Experimental, Food Research Center, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, SP 05508-000, Brazil.ORCID 0000-0001-8768-4772
Katia LeaniProBacLab, Laboratório de Microbiologia de Alimentos, Departamento de Alimentos e Nutrição Experimental, Food Research Center, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, SP 05508-000, Brazil.
Svetoslav Dimitrov TodorovProBacLab, Laboratório de Microbiologia de Alimentos, Departamento de Alimentos e Nutrição Experimental, Food Research Center, Faculdade de Ciências Farmacêuticas, Universidade de São Paulo, São Paulo, SP 05508-000, Brazil.ORCID 0000-0002-6377-3305

Funding

Fundação de Amparo à Pesquisa do Estado de São Paulo grants 2023/05394-9; 2024/01721-8; 2024/13311-9; 2023/14944-2; 2024/08823-0Fundação para a Ciência e Tecnologia UIDB/05937/2020 and UIDP/05937/2020
6 · The paper itself

Abstract

This study evaluated the viability, microbiological composition, functional traits, and safety of probiotic bacteria isolated from commercial products marketed as containing

Indexed as

diacetylD-lactateGITlactic acid bacteriaLacticaseibacillus rhamnosusLimosilactobacillus reuteri

Identifiers

PMID41750869
PMCPMC12939283

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.